← FDA DRUG APPROVALS

FDA ANDA · ANDA074771

CHOLESTYRAMINE

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA074771
TYPE
ANDA
ORIGINAL APPROVAL
1997-07-09
LATEST ACTION
1997-07-09
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

CHOLESTYRAMINEDiscontinued
CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL · POWDER · ORAL
CHOLESTYRAMINEDiscontinued
CHOLESTYRAMINE EQ 4GM RESIN/PACKET · POWDER · ORAL

Approval history

1997-07-09Original — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →